Normotensive OSA Patients With Dipper Circadian Blood Pressure Pattern

Sleep Apnea, Obstructive Clinical Trial

Official title: CPAP Effect in Nocturnal Blood Pressure in Normotensive Patients With Dipper Circadian Pattern and Severe Obstructive Sleep Apnea (OSA)

Status Recruiting

Clinical Trial Summary

The principal objective is to evaluate the effect of CPAP treatment on blood pressure (BP) in normotensive patients with dipper circadian pattern with sleep apnea-hypopnea syndrome (SAHS). The secondary objectives are: i) To evaluate the prevalence of the different circadian patterns of BP in ambulatory blood pressure monitoring (ABPM) ii) To establish the relationship between CPAP compliance and BP response; iii) Identify which ABPM variables and biomarkers are related to BP response; iv) Evaluate changes in the biomarkers' profile with the CPAP treatment. Methodology: Open-label, parallel, prospective, randomized and controlled trial including normotensive patients diagnosed with severe SAHS without significant somnolence. 64 patients with dipper circadian pattern will be included and will be randomized to receive CPAP (32) or conservative treatment (32). ABPM and blood sample collection will be performed at the beginning of the study and at 3 months.

Clinical Trial Description

1. Recruitment: Normotensive subjects referred to the sleep unit of the Hospital Santa Maria (Spain) who are diagnosed of severe OSA (AHI≥30) by a sleep study and dipper circadian blood pattern confirmed by ABPM and who do not present significant somnolence (Epworth≤18) will be included in the study.

2. Definition of the groups: Patients will be randomized to receive one of the following treatments:

1. CPAP: Patients who will receive CPAP treatment. The CPAP titration will be carried out with an automatic or manual CPAP according to usual clinical practice.

2. Conservative treatment: Patients who will receive conservative treatment based on hygienic-dietetic measures.

3. Randomization: It will be carried out with an automated platform

4. Duration of the treatment: All patients randomized to CPAP will begin treatment as soon as possible after randomization, and will continue treatment until the study ends (3 months).

Patients who interrupt treatment will be excluded from the study. ABPM and blood sample collection will be performed on all included patients at the beginning of the study and at 3 months under treatment (CPAP or conservative care).

5. Follow-up: All patients will be evaluated at the beginning of the study (T0), at first month (T1) and at three months (T2), during the follow-up period. ;

Related Conditions & MeSH terms

• Normotensive
• Sleep Apnea Syndromes
• Sleep Apnea, Obstructive

• NCT number: NCT03948373
• Study type: Interventional
• Source: Sociedad Española de Neumología y Cirugía Torácica
• Contact: Ferran Barbé Illa, MD
• Phone: +34 (973) 70 53 72
• Email: febarbe.lleida.ics@gencat.cat
• Status: Recruiting
• Phase: N/A
• Start date: May 7, 2019
• Completion date: December 2025